Tramadol

Generic Name
Tramadol
Brand Names
Conzip, Durela, Qdolo, Ralivia, Ryzolt, Seglentis, Tridural, Ultracet, Ultram, Zytram
Drug Type
Small Molecule
Chemical Formula
C16H25NO2
CAS Number
27203-92-5
Unique Ingredient Identifier
39J1LGJ30J
Background

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of action, tramadol is generally considered a lower-risk opioid option for the treatment of moderate to severe pain. It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of morphine.

Tramadol differs from other traditional opioid medications in that it doesn't just act as a μ-opioid agonist, but also affects monoamines by modulating the effects of neurotransmitters involved in the modulation of pain such as serotonin and norepinpehrine which activate descending pain inhibitory pathways. Tramadol's effects on serotonin and norepinephrine mimic the effects of other SNRI antidepressants such as duloxetine and venlafaxine.

Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms and are also themselves metabolized into active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol's ability to modulate the perception of and response to pain.

Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators. Due to the broad spectrum of targets involved in pain and inflammation, it's not surprising that the evidence has shown that tramadol is effective for a number of pain types including neuropathic pain, post-operative pain, lower back pain, as well as pain associated with labour, osteoarthritis, fibromyalgia, and cancer. Due to its SNRI activity, tramadol also has anxiolytic, antidepressant, and anti-shivering effects which are all frequently found as comorbidities with pain.

Similar to other opioid medications, tramadol poses a risk for development of tolerance, dependence and abuse. If used in higher doses, or with other opioids, there is a dose-related risk of overdose, respiratory depression, and death. However, unlike other opioid medications, tramadol use also carries a risk of seizure and serotonin syndrome, particularly if used with other serotonergic medications.

Indication

Tramadol is approved for the management of moderate to severe pain in adults.

Tramadol is also used off-label in the treatment of premature ejaculation.

Associated Conditions
Acute Pain, Premature Ejaculation, Severe Pain, Acute, moderate, severe Pain, Moderate Pain
Associated Therapies
-

The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)

First Posted Date
2016-07-21
Last Posted Date
2019-10-29
Lead Sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Target Recruit Count
120
Registration Number
NCT02839668
Locations
🇷🇴

IOCN Prof Dr I chiricuta, Cluj-Napoca, Romania

Tramadol Versus Celecoxib in Reducing Pain Associated With IUD Insertion

First Posted Date
2016-07-11
Last Posted Date
2019-04-08
Lead Sponsor
Cairo University
Target Recruit Count
210
Registration Number
NCT02827487
Locations
🇪🇬

Cairo University Hospitals, Cairo, Egypt

Oral Tramadol Versus Diclofenac For Pain Relief Before Outpatient Hysteroscopy:

First Posted Date
2016-05-04
Last Posted Date
2016-05-04
Lead Sponsor
Ain Shams University
Target Recruit Count
102
Registration Number
NCT02760888
Locations
🇪🇬

Ain Shams University, Cairo, Egypt

Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy

First Posted Date
2016-04-13
Last Posted Date
2016-07-06
Lead Sponsor
Cairo University
Target Recruit Count
210
Registration Number
NCT02736071
Locations
🇪🇬

Cairo University Hospitals, Cairo, Egypt

Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women

First Posted Date
2016-04-13
Last Posted Date
2016-07-06
Lead Sponsor
Cairo University
Target Recruit Count
210
Registration Number
NCT02736019
Locations
🇪🇬

Cairo University Hospitals, Cairo, Egypt

Study to Compare Gabapentin to Tramadol in Children With Chronic Neuropathic or Mixed Pain

First Posted Date
2016-03-30
Last Posted Date
2019-10-03
Lead Sponsor
Pharmaceutical Research Management srl
Target Recruit Count
2
Registration Number
NCT02722603
Locations
🇩🇪

Universitaets klinikum Erlangen, Erlangen, Germany

🇳🇱

Erasmus Universitair Medisch Centrum Rotterdam, Rotterdam, Netherlands

Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women

First Posted Date
2016-03-11
Last Posted Date
2016-03-11
Lead Sponsor
Meir Medical Center
Target Recruit Count
100
Registration Number
NCT02706509

Immune Response of Caudally Administrated Tramadol In Pediatric Lower Abdominal Surgery

Phase 2
Completed
Conditions
Interventions
First Posted Date
2016-03-09
Last Posted Date
2017-10-19
Lead Sponsor
Assiut University
Target Recruit Count
60
Registration Number
NCT02703415
Locations
🇪🇬

Faculty of Medicine, Assiut, Egypt

The Analgesic Efficacy of Wound Infiltration With Tramadol

Phase 4
Completed
Conditions
Interventions
First Posted Date
2015-08-07
Last Posted Date
2015-08-07
Lead Sponsor
Yeditepe University Hospital
Target Recruit Count
60
Registration Number
NCT02518438
Locations
🇹🇷

Yeditepe University Hospital, Istanbul, Kozyatagı, Turkey

© Copyright 2024. All Rights Reserved by MedPath